---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-25-000088"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2025-04-22T23:59:59+00:00"
generated_at: "2026-05-23T09:27:55.644201+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Clover Health board member Lee Shapiro to not stand for re-election; Tran to chair committees

## Summary
- Lee Shapiro will not stand for re-election due to American Heart Association chairmanship; departure effective June 10, 2025.
- Thomas Tran appointed Chairman of Audit Committee and Nominating & Corporate Governance Committee effective June 10.
- No disagreement with company operations; Shapiro will finish his term through the annual meeting.
- Board size unchanged at nine; vacancy will be filled as soon as practicable.

## SEC filing metadata
- accession: 0001801170-25-000088
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2025-04-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000088/0001801170-25-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000088/clov-20250421.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-25-000088
- JSON: https://secwatch.observer/filing/0001801170-25-000088.json
- Plain text: https://secwatch.observer/filing/0001801170-25-000088.txt

## Key facts
- Executive change
  Lee A. Shapiro departed as Director at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: not stand for re-election
  - Role: Director
  source text: Mr. Shapiro will fulfill the remainder of his term as member of the Board of Directors and the effective date of his departure will be the Company’s Annual Meeting of Shareholders, June 10, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000088/0001801170-25-000088-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.